NCT07162701View on ClinicalTrials.gov

Body Composition Assessment and Monitoring in Inflammatory Bowel Disease

RecruitingOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

July 15, 2026

Study Completion Date

July 15, 2028

Conditions
Body Composition ChangesMalnutrition
Interventions
DIAGNOSTIC_TEST

Bioimpedance analysis

Patients' body composition will be assessed using bioimpedance analysis (Akern)

Trial Locations (1)

08025

RECRUITING

Unidad de Enfermedad Inflamatoria Intestinal, Barcelona

All Listed Sponsors
collaborator

Grupo Español de trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)

UNKNOWN

lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT07162701 - Body Composition Assessment and Monitoring in Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter